Market Cap 7.88B
Revenue (ttm) 2.35B
Net Income (ttm) 128.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 5.47%
Debt to Equity Ratio 0.00
Volume 14,706,400
Avg Vol 15,692,332
Day's Range N/A - N/A
Shares Out 233.31M
Stochastic %K 90%
Beta 2.40
Analysts Sell
Price Target $31.38

Company Profile

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health a...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 415 851 0195
Address:
2269 Chestnut Street, Suite 523, San Francisco, United States
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 23 at 1:41 AM
$HIMS Sure you have, homie. I'm sure you've mad so much money, you don't want to post numbers. $HOOD is a sub $5 stock, what is your point? Just because Vlad decided to add gambling to his platform does not make it “good” all of a sudden. We are much more confident in our $LFMD order, Monday.
1 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 23 at 12:47 AM
@Yourearegard Oh man. We understand why you’re so upset, lil’ bro...🤣🤣 The real embarrassment is double digit losses 💯 $HIMS $SMCI $LFMD
1 · Reply
USAEquityResearch
USAEquityResearch Aug. 22 at 11:49 PM
$HIMS 📊 USAEquityResearch ▲ 33.78 (+6.03%) Trend: Bullish 📈 RSI (14): 58.4 — neutral territory MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 33.78 | Support: 25.00 20-MA: 29.86 | 50-MA: 32.03 💼 Fundamentals Mkt Cap: $7.88B Fwd P/E: 30.3 FCF: $849.44M (3.78/sh) Total Debt: $1.55B D/E: 477.13 📉 Options (exp 2026-08-28) ATM IV: 71.3% | Skew: -5.0% (call-heavy) P/C Ratio: 0.54 🐂 Bullish lean Max Pain: 30.00 Call wall: 34.00 | Put wall: 33.50 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/HIMS
1 · Reply
Conke_Actual
Conke_Actual Aug. 22 at 11:39 PM
$HIMS gettin rowdy in here this weekend 🤣
0 · Reply
ClarissaLove
ClarissaLove Aug. 22 at 10:50 PM
$LFMD $HIMS I pulled my numbers from the SEC filings and you’re using ChatGPT for your DD. You do realize quarterly reports are filed with the SEC? You’re a fucking idiot. LFMD lost 9000 subscribers from Q1 to Q2 and revenue declined by $3M from Q1 to Q2. Dispute that.
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:36 PM
$HIMS Google it jackass
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:35 PM
$HIMS Useless bot post. Please delete this account
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:34 PM
$HIMS Dumb ass post Are you a child?
0 · Reply
ClarissaLove
ClarissaLove Aug. 22 at 9:28 PM
$HIMS $LFMD I would trust SEC filings over AI chat bots my friend.
0 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 22 at 6:12 PM
LMAO Homie clearly trying to shill $HIMS . This is the information available online my guy, your numbers all BS you pulled out of you’re a$$. Granted, we used ChatGPT for a synopsis however you’re just creaming about numbers with 0 citation. We also beat every single index over the past 3 years. Sucking is not in our vernacular. We know a play when we see one. Monday morning, regadless of what you shill... we will open a large $LFMD position.
1 · Reply
Latest News on HIMS
Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum

Aug 18, 2026, 12:29 PM EDT - 4 days ago

Watch CNBC's full interview with Hims & Hers CEO Andrew Dudum


Hims & Hers Health Earnings Call Transcript: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 12 days ago

Hims & Hers Health Earnings Call Transcript: Q2 2026


Hims & Hers Health Slides: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 12 days ago

Hims & Hers Health Slides: Q2 2026


Hims & Hers Health Earnings release: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 12 days ago

Hims & Hers Health Earnings release: Q2 2026


Hims & Hers Health Quarterly report: Q2 2026

Aug 10, 2026, 5:00 PM EDT - 12 days ago

Hims & Hers Health Quarterly report: Q2 2026


Wednesday's Final Takeaways: Fed Holds Rates & HIMS Lawsuit

Jul 29, 2026, 4:42 PM EDT - 24 days ago

Wednesday's Final Takeaways: Fed Holds Rates & HIMS Lawsuit


Hims & Hers Responds to FTC Lawsuit

Jul 29, 2026, 1:51 PM EDT - 24 days ago

Hims & Hers Responds to FTC Lawsuit


LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 23 at 1:41 AM
$HIMS Sure you have, homie. I'm sure you've mad so much money, you don't want to post numbers. $HOOD is a sub $5 stock, what is your point? Just because Vlad decided to add gambling to his platform does not make it “good” all of a sudden. We are much more confident in our $LFMD order, Monday.
1 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 23 at 12:47 AM
@Yourearegard Oh man. We understand why you’re so upset, lil’ bro...🤣🤣 The real embarrassment is double digit losses 💯 $HIMS $SMCI $LFMD
1 · Reply
USAEquityResearch
USAEquityResearch Aug. 22 at 11:49 PM
$HIMS 📊 USAEquityResearch ▲ 33.78 (+6.03%) Trend: Bullish 📈 RSI (14): 58.4 — neutral territory MACD: bullish, above signal line and rising Volume: normal 📌 Key Levels Resistance: 33.78 | Support: 25.00 20-MA: 29.86 | 50-MA: 32.03 💼 Fundamentals Mkt Cap: $7.88B Fwd P/E: 30.3 FCF: $849.44M (3.78/sh) Total Debt: $1.55B D/E: 477.13 📉 Options (exp 2026-08-28) ATM IV: 71.3% | Skew: -5.0% (call-heavy) P/C Ratio: 0.54 🐂 Bullish lean Max Pain: 30.00 Call wall: 34.00 | Put wall: 33.50 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/HIMS
1 · Reply
Conke_Actual
Conke_Actual Aug. 22 at 11:39 PM
$HIMS gettin rowdy in here this weekend 🤣
0 · Reply
ClarissaLove
ClarissaLove Aug. 22 at 10:50 PM
$LFMD $HIMS I pulled my numbers from the SEC filings and you’re using ChatGPT for your DD. You do realize quarterly reports are filed with the SEC? You’re a fucking idiot. LFMD lost 9000 subscribers from Q1 to Q2 and revenue declined by $3M from Q1 to Q2. Dispute that.
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:36 PM
$HIMS Google it jackass
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:35 PM
$HIMS Useless bot post. Please delete this account
0 · Reply
Paidbasherblock
Paidbasherblock Aug. 22 at 9:34 PM
$HIMS Dumb ass post Are you a child?
0 · Reply
ClarissaLove
ClarissaLove Aug. 22 at 9:28 PM
$HIMS $LFMD I would trust SEC filings over AI chat bots my friend.
0 · Reply
LupusLeoqueGlobalPartnrs
LupusLeoqueGlobalPartnrs Aug. 22 at 6:12 PM
LMAO Homie clearly trying to shill $HIMS . This is the information available online my guy, your numbers all BS you pulled out of you’re a$$. Granted, we used ChatGPT for a synopsis however you’re just creaming about numbers with 0 citation. We also beat every single index over the past 3 years. Sucking is not in our vernacular. We know a play when we see one. Monday morning, regadless of what you shill... we will open a large $LFMD position.
1 · Reply
JohnStockDon
JohnStockDon Aug. 22 at 11:39 AM
$HIMS 45-50 by Halloween? 🎃
0 · Reply
JohnStockDon
JohnStockDon Aug. 22 at 11:38 AM
0 · Reply
Fnkychld
Fnkychld Aug. 22 at 12:30 AM
$HIMS up 110% $110,000
1 · Reply
topstockalerts
topstockalerts Aug. 22 at 12:04 AM
Hims & Hers Health was placed in Visa’s Visa Acquirer Monitoring Program (VAMP) after exceeding acceptable credit-card dispute levels in July, primarily within its weight-loss subscription business, according to internal documents reviewed by Bloomberg. Under the program, Hims will pay an $8 fee per dispute, resulting in an estimated bill of nearly $75,000 due in September. Visa notified the company through payment processor Stripe earlier this month. To exit VAMP, Hims must lower its credit-card dispute rate below 1.5% of transactions for three consecutive months, which Visa considers an acceptable level. The development adds pressure to Hims’ rapidly growing weight-loss business, where subscription and medication-related charges have generated increased customer disputes. The company declined to answer specific questions about Visa’s program, but a spokesperson said Hims has recorded a relatively small number of disputed charges and has implemented measures to address the issue. $HIMS
0 · Reply
Canyonfundstrader2007
Canyonfundstrader2007 Aug. 21 at 11:06 PM
$HIMS got called away today. Good luck
0 · Reply
dogfisher
dogfisher Aug. 21 at 10:06 PM
$HIMS they might have to declare bankruptcy after such a steep penalty. Bloomberg is really desperate for eyeballs.
1 · Reply
AStrokeOfLuck
AStrokeOfLuck Aug. 21 at 9:38 PM
1 · Reply
MaoZedong
MaoZedong Aug. 21 at 9:38 PM
0 · Reply
BAGSNRICHES
BAGSNRICHES Aug. 21 at 9:33 PM
$HIMS CHEERS BULLS! HELL OF A WEEK 🍻
0 · Reply
fishhalibut
fishhalibut Aug. 21 at 9:31 PM
$HIMS Selling calls at a much higher price next week. Thanks everyone. Have a great weekend, fish on! 🤑
0 · Reply
WBM912
WBM912 Aug. 21 at 9:17 PM
$HIMS WHY SO QUIET LATELY ?!?!?! $HIMZ $HOOD AND $HOOW GONNA MAKE A NEW ALL TIME HIGH TOO $WEN HEY SHORTS, DO YOU LIKE "WHEN DEES" NUTS SMACK ACROSS YO FACE?¿¿? 😭😭😭😭😭🤣🤣🤣🤣🤣
0 · Reply
YodaStockInvests
YodaStockInvests Aug. 21 at 8:57 PM
More likely 5x by 2030: $SOFI or $HIMS I hold a solid position in both, I’m leaning SOFI and holding a bit more of it, as member and business growth and management have proven to be more stable over the past 2 years. But if peptides work out…
2 · Reply